Alexion Pharmaceuticals Manager, Strategic Finance in Boston, Massachusetts
Alexion’s Strategic Finance team’s primary purpose is to provide insights and analytics that shape business and investment decisions made by both Alexion’s Executive Leadership Team and Alexion’s Operating Committee. Strategic Finance team members provide an important connection point between Corporate Strategy, Global Finance, Commercial Operations, Business Development, and R&D Portfolio Strategy.
The Strategic Finance Manager will fulfill a critical role on the team by partnering closely with the Business Development team to help assess deals and partnerships. This person will participate in interactions with professionals outside of the company, including investment bankers, VC partners, external consultants, and management from other companies.
The primary focus of the role includes developing company valuation models and designing presentations that highlight risks and opportunities. The Strategic Finance Manager will then use these financial models to develop scenarios and sensitivities that support term negotiations, portfolio prioritization, strategic planning, and other types of decision-making.
As such, we are looking for someone with at least 5-6 years of professional experience with a corporate finance, strategy, consulting, or investment banking background. Key skills required are financial modeling, presentation development, ability to manage up to supervisors, and effective communication. The position will provide ample opportunities for career development through exposure to Alexion leadership, new business units, and potential for rotation after 2-3 years within Finance and Business Development.
Develop and control financial models to support business development, M&A pro-forma analysis, and asset / company valuations
Perform comparable company and transaction analysis to support financing strategies for licensing and acquisitions
Build 3-statement financial models for Alexion and external companies
Conduct asset and partnership valuations which show sensitivities to deal terms and support negotiation strategy
Collaborate with commercial development team to formulate forecast assumptions and market assessments
Analyze corporate structures and valuations of comparable biotech and pharmaceutical companies for executive management
Organize and present research analyst estimates and investor positions
Participate in efforts to source and execute large-scale licensing and acquisition transactions that support long-term growth and discovery at Alexion, including managing relationships with investment banking advisers, assessing venture capital portfolios, and evaluating pipeline opportunities at other pharmaceutical companies
5-6 years of experience in strategic finance position, including Corporate Finance, Investment Banking, Corporate Development, Portfolio Assessment, or Investment Management
Experience in Pharmaceutical/Biotechnology mandatory
Outstanding ability to deliver reports and presentations to senior management
Great computer skills, including Microsoft Excel, Power Point, and Word
Excellent problem solving and organizational skills
Flexibility and ability to adapt to changing conditions and different cultures
Bachelor’s degree required, MBA and/or CFA viewed favorably
Coursework in finance, strategic management, and general business is strongly recommended
Demonstrable accountability through high GPA and extra-curricular participation
Some opportunities happen only once in a lifetime – like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a multinational biopharmaceutical company with approximately 2,500 dedicated employees serving patients in more than 50 countries through the innovation, development, and commercialization of life-changing therapies. As the global leader in complement biology, Alexion developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). Our research efforts focus on novel molecules and targets in the complement cascade, and our development efforts focus on our core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders.
Alexion’s aspiration is to be the most rewarding place to work, where people are empowered to make a difference and where diversity of backgrounds and ideas is encouraged. We are looking for talented individuals who share our passion and commitment to change the lives of patients with rare diseases. We hope you will consider joining our team.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Alexion, please visit www.alexion.com.
Alexion is an Equal Opportunity /Affirmative action employer